Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol

BACKGROUND: Retrospective studies and clinical trials have indicated that β-receptor blockers have an influential role in improving survival and reducing risk of recurrent infarction in patients with myocardial infarction. However, there is still controversy regarding the effects of β-receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales: Moloudi, Abdolrasoul, Sabzi, Feridoun, Rashidi, Shirin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Safnek 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987410/
https://www.ncbi.nlm.nih.gov/pubmed/24757599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987410/
https://www.ncbi.nlm.nih.gov/pubmed/24757599

Ejemplares similares